Abstract:Background: At present, the commercial artificial small diameter (< 6 mm) vascular grafts are still unsatisfactory, due to poor biocompatibility and low long-term patency rate. Objective: This study was to design a novel tissue engineering blood vessel constructed by dog bone marrow derived endothelial progenitor cells and decellularized allogeneic vascular scaffolds. Design, time and setting: From December 2005 to December 2007, the experiment, a randomized control trial of cells an histopathology in vitro, was completed in the Affiliated Drum Tower Hospital of Nanjing University Medical School. Materials: The decellularized canine common carotids were obtained by a detergent-enzymatic procedure; Bone marrow mononuclear cells from mongrel adult dogs were isolated using density gradient centrifugation method and cultured in culture flasks coated with fibronectin. Subsequently, the expanded endothelial progenitor cells were seeded on the decellularized scaffolds, and then co-cultured in the self-made bioreactor to construct the tissue engineering blood vessels. Methods: Bilateral common carotid artery and lateral femoral artery in twenty dogs were all exposed. Three vascular segments from each dog were harvested and then randomly divided into three groups according to the transplant with the tissue engineering blood vessels, decellularized allogeneic vascular scaffolds or autogenous vein. Twenty vessels were implanted into the dogs of each group. Main outcome measures: Immunocytochemical staining was used to identify the cultured endothelial progenitor cells; After 6 months of transplantation, the grafts were retrieved for digital subtraction angiography, pathological test and scanning electron microscope examination. Results: Dog bone marrow mononuclear cells presented a cobblestone-like appearance at 10 days of the culture. The immunocytochemistry results were consistent with the phenotype of endothelial progenitor cells; After highly proliferative endothelial progenitor cells were seeded onto the decellularized scaffold for 10 days, seed cells attached well in the lumen of blood vessels; Six months after implantation, the tissue engineering blood vessels were 85% patent and autogenous vein grafts were 90 patent, which was superior to decellularized allogeneic vascular scaffolds (25%). Conclusion: This study provides a new strategy to develop a tissue engineering blood vessel with excellent biocompatibility and high patency rate by the co-culture of dog bone marrow derived endothelial progenitor cells with decellularized vascular scaffolds.

Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Induction of Differentiation of CD34+ Cells in Vitro and Application in Endothelialization of Blood Vessel Prostheses

[Experiment and Study of Endothelialization of Prostheses with Bone Marrow CD34+ Cells].

Can Endothelial Seeding Enhance Patency and Inhibit Neointimal Hyperplasia? Experimental Studies and Clinical Trial of Endothelial Seeded Venous Prostheses

[Therapeutic Neovascularization with Autologous Bone Marrow CD34+ Cells Transplantation in Hindlimb Ischemia].

Tissue-engineered blood vessels constructed by bone marrow-derived endothelial progenitor cells and decellularized vascular scafflolds

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Heparin/Collagen-REDV Modification of Expanded Polytetrafluoroethylene Improves Regional Anti-thrombosis and Reduces Foreign Body Reactions in Local Tissues

[Construct Tissue-Engineered Bone by Co-Seeding Marrow Stromal Cells and Endothelial Cells].

Biocompatibility Evaluation of Tissue-Engineered Valved Venous Conduit by Reseeding Autologous Bone Marrow-Derived Endothelial Progenitor Cells and Multipotent Adult Progenitor Cells into Heterogeneous Decellularized Venous Matrix.

Enhanced Repair of Segmental Bone Defects of Rats with Hvegf-165 Gene-Modified Endothelial Progenitor Cells Seeded in Nanohydroxyapatite/collagen/poly(l-Lactic Acid) Scaffolds

In situ harvest and in vitro culture of endothelial cells derived from adult canine superficial vein

Administration of in vitro expanded bone marrow-derived endothelial progenitor cells (EPCs) contribute to the development of neointimal thickenings in mouse aortic allografts

Development and validation of small-diameter vascular tissue from a decellularized scaffold coated with heparin and vascular endothelial growth factor.

In Vitro Study of Endothelial Cells Lining Vascular Grafts Grown Within the Recipient's Peritoneal Cavity.

Roles and mechanisms of endothelial progenitor cells in the post-transplant tacho-endothelialization of vascular prosthesis

The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation

Successful Application of Biodegradable Vascular Scaffolds in the Dog Femoral Artery Transplantation

Tissue Engineering of Small-Diameter Vascular Grafts by Endothelial Progenitor Cells Seeding Heparin-Coated Decellularized Scaffolds.

Preliminary Study of in Vitro Construction of Small-Diameter Vascular Graft by Seeding Cells Onto Decellullarized Arterial Matrix

Synthetic Eptfe Grafts Coated with an Anti-Cd133 Antibody-Functionalized Heparin/collagen Multilayer with Rapid in Vivo Endothelialization Properties.